世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global GMP Tumor Necrosis Factor Alpha Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2601
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、GMP腫瘍壊死因子アルファのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（25μg、50μg、その他）、用途別市場規模（細胞/遺伝子治療、組織工学製品、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・GMP腫瘍壊死因子アルファの市場動向
・企業の競争状況、市場シェア
・GMP腫瘍壊死因子アルファの種類別市場規模（25μg、50μg、その他）
・GMP腫瘍壊死因子アルファの用途別市場規模（細胞/遺伝子治療、組織工学製品、その他）
・GMP腫瘍壊死因子アルファの北米市場規模2016-2027（アメリカ、カナダ）
・GMP腫瘍壊死因子アルファのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・GMP腫瘍壊死因子アルファのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・GMP腫瘍壊死因子アルファの中南米市場規模2016-2027（メキシコ、ブラジル）
・GMP腫瘍壊死因子アルファの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Miltenyi Biotec、Bio-Techne、GE Healthcare、Lonza、CellGenix、ReproCELL、PeproTech、Sino Biological、Creative Bioarray、Akron Biotech、Almog）
・結論

Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of other cell types such as T cells, natural killer cells (NK cells) and neutrophils.

Market Analysis and Insights: Global GMP Tumor Necrosis Factor Alpha Market
The global GMP Tumor Necrosis Factor Alpha market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GMP Tumor Necrosis Factor Alpha market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GMP Tumor Necrosis Factor Alpha market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GMP Tumor Necrosis Factor Alpha market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GMP Tumor Necrosis Factor Alpha market.

Global GMP Tumor Necrosis Factor Alpha Scope and Market Size
GMP Tumor Necrosis Factor Alpha market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global GMP Tumor Necrosis Factor Alpha market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
25μg
50μg
Others

Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Miltenyi Biotec
Bio-Techne
GE Healthcare
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 25μg
1.2.3 50μg
1.2.4 Others
1.3 Market by Application
1.3.1 Global GMP Tumor Necrosis Factor Alpha Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cell/Gene Therapy
1.3.3 Tissue-Engineered Products
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global GMP Tumor Necrosis Factor Alpha Market Perspective (2016-2027)
2.2 GMP Tumor Necrosis Factor Alpha Growth Trends by Regions
2.2.1 GMP Tumor Necrosis Factor Alpha Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 GMP Tumor Necrosis Factor Alpha Historic Market Share by Regions (2016-2021)
2.2.3 GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Regions (2022-2027)
2.3 GMP Tumor Necrosis Factor Alpha Industry Dynamic
2.3.1 GMP Tumor Necrosis Factor Alpha Market Trends
2.3.2 GMP Tumor Necrosis Factor Alpha Market Drivers
2.3.3 GMP Tumor Necrosis Factor Alpha Market Challenges
2.3.4 GMP Tumor Necrosis Factor Alpha Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top GMP Tumor Necrosis Factor Alpha Players by Revenue
3.1.1 Global Top GMP Tumor Necrosis Factor Alpha Players by Revenue (2016-2021)
3.1.2 Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Players (2016-2021)
3.2 Global GMP Tumor Necrosis Factor Alpha Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by GMP Tumor Necrosis Factor Alpha Revenue
3.4 Global GMP Tumor Necrosis Factor Alpha Market Concentration Ratio
3.4.1 Global GMP Tumor Necrosis Factor Alpha Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Tumor Necrosis Factor Alpha Revenue in 2020
3.5 GMP Tumor Necrosis Factor Alpha Key Players Head office and Area Served
3.6 Key Players GMP Tumor Necrosis Factor Alpha Product Solution and Service
3.7 Date of Enter into GMP Tumor Necrosis Factor Alpha Market
3.8 Mergers & Acquisitions, Expansion Plans

4 GMP Tumor Necrosis Factor Alpha Breakdown Data by Type
4.1 Global GMP Tumor Necrosis Factor Alpha Historic Market Size by Type (2016-2021)
4.2 Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Type (2022-2027)

5 GMP Tumor Necrosis Factor Alpha Breakdown Data by Application
5.1 Global GMP Tumor Necrosis Factor Alpha Historic Market Size by Application (2016-2021)
5.2 Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America GMP Tumor Necrosis Factor Alpha Market Size (2016-2027)
6.2 North America GMP Tumor Necrosis Factor Alpha Market Size by Type
6.2.1 North America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021)
6.2.2 North America GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027)
6.2.3 North America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2027)
6.3 North America GMP Tumor Necrosis Factor Alpha Market Size by Application
6.3.1 North America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021)
6.3.2 North America GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027)
6.3.3 North America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2027)
6.4 North America GMP Tumor Necrosis Factor Alpha Market Size by Country
6.4.1 North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021)
6.4.2 North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe GMP Tumor Necrosis Factor Alpha Market Size (2016-2027)
7.2 Europe GMP Tumor Necrosis Factor Alpha Market Size by Type
7.2.1 Europe GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021)
7.2.2 Europe GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027)
7.2.3 Europe GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2027)
7.3 Europe GMP Tumor Necrosis Factor Alpha Market Size by Application
7.3.1 Europe GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021)
7.3.2 Europe GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027)
7.3.3 Europe GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2027)
7.4 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country
7.4.1 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021)
7.4.2 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size (2016-2027)
8.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type
8.2.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021)
8.2.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027)
8.2.3 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2027)
8.3 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application
8.3.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021)
8.3.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027)
8.3.3 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2027)
8.4 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region
8.4.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2016-2021)
8.4.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America GMP Tumor Necrosis Factor Alpha Market Size (2016-2027)
9.2 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type
9.2.1 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021)
9.2.2 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027)
9.2.3 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2027)
9.3 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application
9.3.1 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021)
9.3.2 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027)
9.3.3 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2027)
9.4 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country
9.4.1 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021)
9.4.2 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size (2016-2027)
10.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type
10.2.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021)
10.2.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027)
10.2.3 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2027)
10.3 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application
10.3.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021)
10.3.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027)
10.3.3 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2027)
10.4 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country
10.4.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021)
10.4.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Miltenyi Biotec
11.1.1 Miltenyi Biotec Company Details
11.1.2 Miltenyi Biotec Business Overview
11.1.3 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Introduction
11.1.4 Miltenyi Biotec Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.1.5 Miltenyi Biotec Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne GMP Tumor Necrosis Factor Alpha Introduction
11.2.4 Bio-Techne Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.2.5 Bio-Techne Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare GMP Tumor Necrosis Factor Alpha Introduction
11.3.4 GE Healthcare Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza GMP Tumor Necrosis Factor Alpha Introduction
11.4.4 Lonza Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.4.5 Lonza Recent Development
11.5 CellGenix
11.5.1 CellGenix Company Details
11.5.2 CellGenix Business Overview
11.5.3 CellGenix GMP Tumor Necrosis Factor Alpha Introduction
11.5.4 CellGenix Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.5.5 CellGenix Recent Development
11.6 ReproCELL
11.6.1 ReproCELL Company Details
11.6.2 ReproCELL Business Overview
11.6.3 ReproCELL GMP Tumor Necrosis Factor Alpha Introduction
11.6.4 ReproCELL Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.6.5 ReproCELL Recent Development
11.7 PeproTech
11.7.1 PeproTech Company Details
11.7.2 PeproTech Business Overview
11.7.3 PeproTech GMP Tumor Necrosis Factor Alpha Introduction
11.7.4 PeproTech Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.7.5 PeproTech Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Details
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological GMP Tumor Necrosis Factor Alpha Introduction
11.8.4 Sino Biological Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.8.5 Sino Biological Recent Development
11.9 Creative Bioarray
11.9.1 Creative Bioarray Company Details
11.9.2 Creative Bioarray Business Overview
11.9.3 Creative Bioarray GMP Tumor Necrosis Factor Alpha Introduction
11.9.4 Creative Bioarray Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.9.5 Creative Bioarray Recent Development
11.10 Akron Biotech
11.10.1 Akron Biotech Company Details
11.10.2 Akron Biotech Business Overview
11.10.3 Akron Biotech GMP Tumor Necrosis Factor Alpha Introduction
11.10.4 Akron Biotech Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.10.5 Akron Biotech Recent Development
11.11 Almog
11.11.1 Almog Company Details
11.11.2 Almog Business Overview
11.11.3 Almog GMP Tumor Necrosis Factor Alpha Introduction
11.11.4 Almog Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
11.11.5 Almog Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 25μg
Table 3. Key Players of 50μg
Table 4. Key Players of Others
Table 5. Global GMP Tumor Necrosis Factor Alpha Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global GMP Tumor Necrosis Factor Alpha Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global GMP Tumor Necrosis Factor Alpha Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global GMP Tumor Necrosis Factor Alpha Market Share by Regions (2016-2021)
Table 9. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global GMP Tumor Necrosis Factor Alpha Market Share by Regions (2022-2027)
Table 11. GMP Tumor Necrosis Factor Alpha Market Trends
Table 12. GMP Tumor Necrosis Factor Alpha Market Drivers
Table 13. GMP Tumor Necrosis Factor Alpha Market Challenges
Table 14. GMP Tumor Necrosis Factor Alpha Market Restraints
Table 15. Global GMP Tumor Necrosis Factor Alpha Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global GMP Tumor Necrosis Factor Alpha Market Share by Players (2016-2021)
Table 17. Global Top GMP Tumor Necrosis Factor Alpha Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GMP Tumor Necrosis Factor Alpha as of 2020)
Table 18. Ranking of Global Top GMP Tumor Necrosis Factor Alpha Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by GMP Tumor Necrosis Factor Alpha Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players GMP Tumor Necrosis Factor Alpha Product Solution and Service
Table 22. Date of Enter into GMP Tumor Necrosis Factor Alpha Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 25. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2016-2021)
Table 26. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global GMP Tumor Necrosis Factor Alpha Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Application (2016-2021)
Table 30. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 33. North America GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021) (US$ Million)
Table 35. North America GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2022-2027) & (US$ Million)
Table 62. Miltenyi Biotec Company Details
Table 63. Miltenyi Biotec Business Overview
Table 64. Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Product
Table 65. Miltenyi Biotec Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 66. Miltenyi Biotec Recent Development
Table 67. Bio-Techne Company Details
Table 68. Bio-Techne Business Overview
Table 69. Bio-Techne GMP Tumor Necrosis Factor Alpha Product
Table 70. Bio-Techne Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 71. Bio-Techne Recent Development
Table 72. GE Healthcare Company Details
Table 73. GE Healthcare Business Overview
Table 74. GE Healthcare GMP Tumor Necrosis Factor Alpha Product
Table 75. GE Healthcare Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 76. GE Healthcare Recent Development
Table 77. Lonza Company Details
Table 78. Lonza Business Overview
Table 79. Lonza GMP Tumor Necrosis Factor Alpha Product
Table 80. Lonza Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 81. Lonza Recent Development
Table 82. CellGenix Company Details
Table 83. CellGenix Business Overview
Table 84. CellGenix GMP Tumor Necrosis Factor Alpha Product
Table 85. CellGenix Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 86. CellGenix Recent Development
Table 87. ReproCELL Company Details
Table 88. ReproCELL Business Overview
Table 89. ReproCELL GMP Tumor Necrosis Factor Alpha Product
Table 90. ReproCELL Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 91. ReproCELL Recent Development
Table 92. PeproTech Company Details
Table 93. PeproTech Business Overview
Table 94. PeproTech GMP Tumor Necrosis Factor Alpha Product
Table 95. PeproTech Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 96. PeproTech Recent Development
Table 97. Sino Biological Company Details
Table 98. Sino Biological Business Overview
Table 99. Sino Biological Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 100. Sino Biological Recent Development
Table 101. Creative Bioarray Company Details
Table 102. Creative Bioarray Business Overview
Table 103. Creative Bioarray GMP Tumor Necrosis Factor Alpha Product
Table 104. Creative Bioarray Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 105. Creative Bioarray Recent Development
Table 106. Akron Biotech Company Details
Table 107. Akron Biotech Business Overview
Table 108. Akron Biotech GMP Tumor Necrosis Factor Alpha Product
Table 109. Akron Biotech Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 110. Akron Biotech Recent Development
Table 111. Almog Company Details
Table 112. Almog Business Overview
Table 113. Almog GMP Tumor Necrosis Factor Alpha Product
Table 114. Almog Revenue in GMP Tumor Necrosis Factor Alpha Business (2016-2021) & (US$ Million)
Table 115. Almog Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GMP Tumor Necrosis Factor Alpha Market Share by Type: 2020 VS 2027
Figure 2. 25μg Features
Figure 3. 50μg Features
Figure 4. Others Features
Figure 5. Global GMP Tumor Necrosis Factor Alpha Market Share by Application: 2020 VS 2027
Figure 6. Cell/Gene Therapy Case Studies
Figure 7. Tissue-Engineered Products Case Studies
Figure 8. Others Case Studies
Figure 9. GMP Tumor Necrosis Factor Alpha Report Years Considered
Figure 10. Global GMP Tumor Necrosis Factor Alpha Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global GMP Tumor Necrosis Factor Alpha Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global GMP Tumor Necrosis Factor Alpha Market Share by Regions: 2020 VS 2027
Figure 13. Global GMP Tumor Necrosis Factor Alpha Market Share by Regions (2022-2027)
Figure 14. Global GMP Tumor Necrosis Factor Alpha Market Share by Players in 2020
Figure 15. Global Top GMP Tumor Necrosis Factor Alpha Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GMP Tumor Necrosis Factor Alpha as of 2020
Figure 16. The Top 10 and 5 Players Market Share by GMP Tumor Necrosis Factor Alpha Revenue in 2020
Figure 17. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2016-2021)
Figure 18. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2022-2027)
Figure 19. North America GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America GMP Tumor Necrosis Factor Alpha Market Share by Type (2016-2027)
Figure 21. North America GMP Tumor Necrosis Factor Alpha Market Share by Application (2016-2027)
Figure 22. North America GMP Tumor Necrosis Factor Alpha Market Share by Country (2016-2027)
Figure 23. United States GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe GMP Tumor Necrosis Factor Alpha Market Share by Type (2016-2027)
Figure 27. Europe GMP Tumor Necrosis Factor Alpha Market Share by Application (2016-2027)
Figure 28. Europe GMP Tumor Necrosis Factor Alpha Market Share by Country (2016-2027)
Figure 29. Germany GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Share by Type (2016-2027)
Figure 37. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Share by Application (2016-2027)
Figure 38. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Share by Region (2016-2027)
Figure 39. China GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America GMP Tumor Necrosis Factor Alpha Market Share by Type (2016-2027)
Figure 47. Latin America GMP Tumor Necrosis Factor Alpha Market Share by Application (2016-2027)
Figure 48. Latin America GMP Tumor Necrosis Factor Alpha Market Share by Country (2016-2027)
Figure 49. Mexico GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Share by Type (2016-2027)
Figure 53. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Share by Application (2016-2027)
Figure 54. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Share by Country (2016-2027)
Figure 55. Turkey GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Miltenyi Biotec Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 59. Bio-Techne Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 60. GE Healthcare Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 61. Lonza Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 62. CellGenix Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 63. ReproCELL Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 64. PeproTech Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 65. Sino Biological Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 66. Creative Bioarray Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 67. Akron Biotech Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 68. Almog Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

Global GMP Tumor Necrosis Factor Alpha Market Size, Status and Forecast 2021-2027
QYR2104Z2601 2021年4月 99Pages
QYResearch社発行の本調査資料では、GMP腫瘍壊死因子アルファのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（25μg、50μg、その他）、用途別市場規模（細胞/遺伝子治療、組織工学製品、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の皮膚壊死治療市場規模・現状・予測（2021年-2027年）

Global Dermal Necrosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1802 2021年4月 96Pages
QYResearch社発行の本調査資料では、皮膚壊死治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、コルチコステロイド）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の無血管性壊死市場規模・現状・予測（2021年-2027年）

Global Avascular Necrosis Market Size, Status and Forecast 2021-2027
QYR2104Z0665 2021年4月 126Pages
QYResearch社発行の本調査資料では、無血管性壊死のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN））、用途別市場規模（病院、クリニック、診断センター、外来手術センター）、主要地域...

世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年）

Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, Status and Forecast 2021-2027
QYR2104Z0392 2021年4月 85Pages
QYResearch社発行の本調査資料では、抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（5ml、10ml、15ml）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北...

世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年）

Global Antihemophilic Factor (Recombinant) Market Size, Status and Forecast 2021-2027
QYR2104Z0393 2021年4月 100Pages
QYResearch社発行の本調査資料では、抗血友病因子（組換え）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（250IU、500IU、1000IU、1500IU、2000IU）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、...

世界の凝固因子市場規模・現状・予測（2021年-2027年）

Global Clotting Factor Market Size, Status and Forecast 2021-2027
QYR2104Z1391 2021年4月 95Pages
QYResearch社発行の本調査資料では、凝固因子のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の凝固因子市場規模・現状・予測（2021年-2027年）

世界の腫瘍治療フィールド市場規模・現状・予測（2021年-2027年）

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2021-2027
QYR2104Z5761 2021年4月 94Pages
QYResearch社発行の本調査資料では、腫瘍治療フィールドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、診療所、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0421 2021年4月 98Pages
QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抽出注入、プリチャージ注入）、用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）、主要地域別市場規模（...

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年） Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of …
世界の皮膚壊死治療市場規模・現状・予測（2021年-2027年） Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough…
世界の無血管性壊死市場規模・現状・予測（2021年-2027年） Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby jo…
世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…